Author:
Buhl Roland,Dreher Michael,Mattiucci-Guehlke Muriel,Emerson-Stadler Rachel,Eckhardt Sebastian,Taube Christian,Vogelmeier Claus F.
Funder
Boehringer Ingelheim
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference27 articles.
1. Lopez-Campos JL, Calero C, Quintana-Gallego E. Symptom variability in COPD: a narrative review. Int J Chron Obstruct Pulmon Dis. 2013;8:231–8.
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: 2023 report. 2022. https://goldcopd.org/wp-content/uploads/2022/11/GOLD-2023-ver-1.0-14Nov2022_WMV.pdf. Accessed 17 Nov 2022.
3. Miravitlles M, Auladell-Rispau A, Monteagudo M, Vazquez-Niebla JC, Mohammed J, Nunez A, et al. Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD. Eur Respir Rev. 2021;30(160): 210075.
4. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: 2022 report. 2021. Available from: https://goldcopd.org/wp-content/uploads/2021/12/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf. Accessed 12 Oct 2022.
5. Buhl R, Dreher M, Korn S, Taube C, Stock C, Zehendner CM, et al. A non-interventional study of tiotropium/olodaterol versus any triple combination therapy for chronic obstructive pulmonary disease: The EVELUT® study protocol. Int J Chron Obstruct Pulmon Dis. 2020;15:2601–8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献